Egetis Therapeutics AB (publ) (EGTX.ST)
SEK 6.65
(-8.65%)
SEK 6.65
(-8.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -278.4 Million | -173.5 Million | -130.11 Million | -134.63 Million | -62.64 Million | -80.31 Million |
| Net Income | -326.9 Million | -193.8 Million | -104.54 Million | -179.12 Million | -61.42 Million | -85 Million |
| Depreciation & Amortization | 3.6 Million | 2.7 Million | 2.45 Million | 395 Thousand | 210 Thousand | - |
| Deferred income taxes | 15.7 Million | - | -1.08 Million | 1.47 Million | - | - |
| Stock-based compensation | 8 Million | 8.8 Million | 1.2 Million | 557 Thousand | - | - |
| Change in working capital | 30.9 Million | 10.9 Million | -28.25 Million | 42.05 Million | -282 Thousand | 4.69 Million |
| Other non-cash items | 6 Million | -2.1 Million | 154 Thousand | 5000.00 | -1.14 Million | -1000.00 |
| Investing Cash Flow | -100 Thousand | -1.7 Million | -5.95 Million | -59.54 Million | - | - |
| Investments in PPE | - | - | -172 Thousand | -24 Thousand | - | - |
| Acquisitions | - | -1.7 Million | -5 Million | -59.52 Million | - | - |
| Investment purchases | - | - | -785 Thousand | - | - | - |
| Sales/Maturities of investments | - | - | 5.8 Million | - | - | - |
| Other Investing Activities | - | - | -5.8 Million | 1000.00 | - | - |
| Financing Cash Flow | 458.9 Million | 155.7 Million | -8.9 Million | 228.4 Million | 86.72 Million | 655 Thousand |
| Debt repayment | -105.8 Million | -9.1 Million | -7.5 Million | -215 Thousand | -216 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 355.6 Million | 164.8 Million | - | 250.75 Million | 91.25 Million | 655 Thousand |
| Other Financing Activities | 100 Thousand | 164.8 Million | -1.4 Million | -22.13 Million | -4.32 Million | 655 Thousand |
| Accounts receivables | -22.9 Million | -10.7 Million | 3.08 Million | 16.42 Million | 49 Thousand | -6.27 Million |
| Accounts payables | 53.8 Million | 21.6 Million | -31.33 Million | 25.62 Million | -3.96 Million | 9.2 Million |
| Inventory | - | - | - | - | 1000.00 | - |
| Other working capital | 53.8 Million | 21.6 Million | -31.3 Million | 25.62 Million | 3.63 Million | 1.76 Million |
| Cash at beginning of period | 127.7 Million | 144 Million | 287.85 Million | 255.1 Million | 229.87 Million | 309.53 Million |
| Cash at end of period | 303.3 Million | 127.7 Million | 143.96 Million | 287.85 Million | 255.1 Million | 229.87 Million |
| Capital Expenditure | - | - | -172 Thousand | -24 Thousand | - | - |
| Effect of forex changes on cash | -4.8 Million | 3.2 Million | 1.08 Million | -1.47 Million | 1.14 Million | 912 Thousand |
| Net cash flow / Change in cash | 175.6 Million | -16.3 Million | -143.88 Million | 32.74 Million | 25.22 Million | -79.65 Million |
| Free Cash Flow | -278.4 Million | -173.5 Million | -130.28 Million | -134.66 Million | -62.64 Million | -80.31 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -71.9 Million | -75 Million | -326.9 Million | -86.3 Million | -86.2 Million | -79.5 Million |
| Depreciation & Amortization | - | - | 3.6 Million | 900 Thousand | 900 Thousand | 900 Thousand |
| Deferred income taxes | - | - | 15.7 Million | - | - | 500 Thousand |
| Stock-based compensation | - | - | 8 Million | 3.8 Million | 3.1 Million | -1.4 Million |
| Change in working capital | 23.3 Million | 10.3 Million | 30.9 Million | 35.1 Million | -11.6 Million | 15.6 Million |
| Other non-cash items | -31.1 Million | -1 Million | 6 Million | 8.6 Million | 3.8 Million | -300 Thousand |
| Investing Cash Flow | - | - | -100 Thousand | 400 Thousand | -500 Thousand | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | 400 Thousand | -500 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 500 Thousand | -500 Thousand | - |
| Financing Cash Flow | -700 Thousand | -600 Thousand | 458.9 Million | 264.89 Million | -600 Thousand | -600 Thousand |
| Debt repayment | -600 Thousand | -600 Thousand | -105.8 Million | -105.8 Million | -600 Thousand | -600 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 355.6 Million | 159.6 Million | - | - |
| Other Financing Activities | -600 Thousand | - | 100 Thousand | 200 Thousand | -600 Thousand | -600 Thousand |
| Accounts receivables | -5.8 Million | 8.5 Million | -22.9 Million | -9 Million | -20 Million | 2.1 Million |
| Accounts payables | 29.1 Million | 1.8 Million | 53.8 Million | 44.1 Million | 8.4 Million | 13.5 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 29.1 Million | 1.8 Million | 53.8 Million | 44.1 Million | 8.4 Million | 13.6 Million |
| Cash at beginning of period | 251.7 Million | 303.3 Million | 127.7 Million | 85 Million | 179.2 Million | 243.5 Million |
| Cash at end of period | 192.6 Million | 251.7 Million | 303.3 Million | 303.3 Million | 85 Million | 179.2 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -2.1 Million | 4.4 Million | -4.8 Million | -5.2 Million | - | 500 Thousand |
| Net cash flow / Change in cash | -59.1 Million | -51.6 Million | 175.6 Million | 218.3 Million | -94.2 Million | -64.3 Million |
| Free Cash Flow | -56.4 Million | -55.4 Million | -278.4 Million | -41.7 Million | -93.1 Million | -64.2 Million |
WAYS
INFIBEAM
DRIL
RTNPOWER
BRI
ALDE